2023
|
Invention
|
Monoclonal antibody, and method for detecting a1 beta-casein. The purpose of the present inventio... |
2021
|
Invention
|
Anti-meflin antibody for use in treatment of cancer in subject having cancer, and pharmaceutical ... |
|
Invention
|
Anti-meflin antibody for use in treating cancer in subject having cancer, and pharmaceutical comp... |
2020
|
Invention
|
Antibody-drug conjugates and use of antibodies for drug delivery.
One purpose of the present inv... |
|
Invention
|
Use of antibody-drug conjugates and antibodies for drug delivery. An objective of the present inv... |
2019
|
Invention
|
Novel monoclonal antibody having anti-inflammatory action.
Provided is a more effective anti-inf... |
|
Invention
|
Novel monoclonal antibody having anti-inflammatory action. Provided is an anti-inflammatory drug ... |
2018
|
Invention
|
Pharmaceutical composition comprising iron chelator exhibiting antitumor activity, antibacterial ... |
2017
|
Invention
|
Antibody against prorenin receptor or antigen-binding fragment of said antibody, and use of same.... |
2011
|
Invention
|
Therapeutic agent for traumatic neurological disorders. Provided is a novel drug for treating tra... |
|
Invention
|
Adjuvant having anti-tumor effect. Disclosed is an adjuvant that has an anti-tumor effect and tha... |
2010
|
Invention
|
Suppressant for atherosclerosis.
The objective of the present invention is to provide an agent w... |
|
Invention
|
Agent for prevention of atherosclerosis. Disclosed is a medicinal agent which is effective on the... |